Novartis Venture Fund
Focus: Healthtech & bioNovartis Venture Fund took part in 2 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $137m. By money raised, its biggest sector was Healthtech & bio. The largest was Sidewinder Therapeutics's $137m Series B round. The most recent was Anaheim Bio's Series A round in November 2026.
Deployed as lead$137m
Rounds led1
Rounds joined2
Largest round$137m